South Korea
· Delayed Price · Currency is KRW Jeil Pharma Holdings Company Description
Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea.
The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products.
It also provides finished dosage forms in the areas of anti-bacteria and anti-fungal, anti-virus, cardiovascular, endocrinology, neurology, gastrointestinal, urology, oncology, anti-histamine, rheumatology, respiratory, otolaryngological, heaptic, laxatives, and purgatives.
The company exports its products to approximately 40 countries in the Association of Southeast Asian Nations, Central and South America, Africa, etc. The company was founded in 1959 and is headquartered in Seoul, South Korea.
| Country | South Korea |
| Founded | 1959 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 35 |
| CEO | Seung-Soo Han |
Contact Details
Address: 343, Sapyeong-daero Seoul, 06543 South Korea | |
| Phone | 82 2 549 7451 |
| Website | jeilpharm.co.kr |
Stock Details
| Ticker Symbol | 002620 |
| Exchange | Korea Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7002620003 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Seung-Soo Han | Chairman of The Board and Chief Executive Officer |